Arcosa Inc. (ACA)

NEE, OGE, POR and ACA are capitalizing on soaring wind energy demand, with strong backlogs and expansion plans boosting growth.

Arcosa (ACA) is well positioned to outperform the market, as it exhibits above-average growth in financials.

The mean of analysts' price targets for Arcosa (ACA) points to a 26.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts i...

DALLAS--(BUSINESS WIRE)--Arcosa, Inc. (NYSE: ACA) (“Arcosa” or the “Company”), a provider of infrastructure-related products and solutions, today announced that its Board of Directors has declared a r...

Arcosa, Inc. (NYSE:ACA ) Q1 2025 Earnings Conference Call May 7, 2025 8:30 AM ET Company Participants Erin Drabek - Director of Investor Relations Antonio Carrillo - President and Chief Executive Offi...

Arcosa (ACA) came out with quarterly earnings of $0.49 per share, beating the Zacks Consensus Estimate of $0.29 per share. This compares to earnings of $0.73 per share a year ago.

DALLAS--(BUSINESS WIRE)--Arcosa, Inc. (NYSE: ACA) (“Arcosa,” the “Company,” “We,” or “Our”), a provider of infrastructure-related products and solutions, today announced results for the first quarter ...

ARCB, ACA and BAND have been added to the Zacks Rank #5 (Strong Sell) List on May 2, 2025.

The healthcare company also struck a deal with Novo Nordisk to sell Wegovy at a reduced price for cash-paying customers through its pharmacies.

DALLAS--(BUSINESS WIRE)--Arcosa, Inc. (NYSE: ACA) (“Arcosa” or the “Company”), a provider of infrastructure-related products and solutions, today announced that it will release results for the first q...